Schantel Williams
Overview
Explore the profile of Schantel Williams including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
635
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mosconi L, Williams S, Carlton C, Andy C, Fauci F, Zarate C, et al.
Menopause
. 2025 Mar;
PMID: 40067757
Objective: This study aimed to investigate neurophysiological correlates of subjective cognitive decline (SCD) among midlife women at risk for Alzheimer's disease (AD). Methods: We examined 156 cognitively normal perimenopausal and...
2.
Mosconi L, Nerattini M, Williams S, Fink M
J Clin Endocrinol Metab
. 2025 Jan;
PMID: 39815764
Accumulating evidence suggests that the effects of menopausal hormone therapy (MHT) on risk of Alzheimer's disease (AD) and all-cause dementia are influenced by timing of initiation relative to age and...
3.
Nerattini M, Williams S, Andy C, Carlton C, Zarate C, Boneu C, et al.
PLoS One
. 2025 Jan;
20(1):e0317303.
PMID: 39804890
Testosterone, an essential sex steroid hormone, influences brain health by impacting neurophysiology and neuropathology throughout the lifespan in both genders. However, human research in this area is limited, particularly in...
4.
Mosconi L, Nerattini M, Berti V, Matthews D, Andy C, Williams S, et al.
J Nucl Med
. 2025 Jan;
66(2):331-332.
PMID: 39778966
No abstract available.
5.
Mosconi L, Nerattini M, Matthews D, Jett S, Andy C, Williams S, et al.
Sci Rep
. 2024 Jun;
14(1):12680.
PMID: 38902275
17β-estradiol, the most biologically active estrogen, exerts wide-ranging effects in brain through its action on estrogen receptors (ERs), influencing higher-order cognitive function and neurobiological aging. However, our knowledge of ER...
6.
Nerattini M, Rubino F, Jett S, Andy C, Boneu C, Zarate C, et al.
Front Dement
. 2024 May;
2.
PMID: 38774256
Introduction: In preclinical studies, menopausal elevations in pituitary gonadotropins, follicle-stimulating hormone (FSH) and luteinizing hormone (LH), trigger Alzheimer's disease (AD) pathology and synaptic loss in female animals. Herein, we took...
7.
Andy C, Nerattini M, Jett S, Carlton C, Zarate C, Boneu C, et al.
Front Endocrinol (Lausanne)
. 2024 Mar;
15:1350318.
PMID: 38501109
Introduction: Despite evidence from preclinical studies suggesting estrogen's neuroprotective effects, the use of menopausal hormone therapy (MHT) to support cognitive function remains controversial. Methods: We used random-effect meta-analysis and multi-level...
8.
Mosconi L, Williams S, Carlton C, Zarate C, Boneu C, Fauci F, et al.
Sci Rep
. 2024 Mar;
14(1):5519.
PMID: 38448497
Emerging evidence implicates chronic psychological stress as a risk factor for Alzheimer's disease (AD). Herein, we examined the relationships between serum cortisol and multimodality brain AD biomarkers in 277 cognitively...
9.
Nerattini M, Jett S, Andy C, Carlton C, Zarate C, Boneu C, et al.
Front Aging Neurosci
. 2023 Nov;
15:1260427.
PMID: 37937120
Introduction: Despite a large preclinical literature demonstrating neuroprotective effects of estrogen, use of menopausal hormone therapy (HT) for Alzheimer's disease (AD) risk reduction has been controversial. Herein, we conducted a...
10.
Jett S, Boneu C, Zarate C, Carlton C, Kodancha V, Nerattini M, et al.
Front Aging Neurosci
. 2023 Jun;
15:1183228.
PMID: 37273652
Many lines of evidence suggest that mitochondria have a central role in aging-related neurodegenerative diseases, such as Alzheimer's disease (AD). Mitochondrial dysfunction, cerebral energy dysmetabolism and oxidative damage increase with...